Cerdelga® (eliglustat)
| Full Name | Cerdelga® (eliglustat) |
| Drug | Cerdelga |
| Manufacturer | Sanofi Genzyme |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test |
| Disease | Gaucher Type I Disease |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | hcp.cerdelga.com |